JPMorgan Chase & Co. Boosts Aflac (NYSE:AFL) Price Target to $100.00

Aflac (NYSE:AFL - Get Free Report) had its price target increased by investment analysts at JPMorgan Chase & Co. from $96.00 to $100.00 in a report issued on Tuesday,Benzinga reports. The firm presently has a "neutral" rating on the financial services provider's stock. JPMorgan Chase & Co.'s price objective would suggest a potential downside of 3.16% from the stock's previous close.

AFL has been the topic of a number of other research reports. Piper Sandler lifted their price objective on Aflac from $118.00 to $124.00 and gave the stock an "overweight" rating in a research report on Wednesday, April 2nd. Raymond James Financial reduced their price objective on Aflac from $115.00 to $110.00 and set an "outperform" rating on the stock in a research report on Thursday, May 29th. Wall Street Zen downgraded Aflac from a "hold" rating to a "sell" rating in a research report on Monday, May 5th. Morgan Stanley raised their target price on Aflac from $100.00 to $105.00 and gave the stock an "equal weight" rating in a research note on Monday, May 19th. Finally, Keefe, Bruyette & Woods raised their target price on Aflac from $104.00 to $106.00 and gave the stock a "market perform" rating in a research note on Wednesday, May 7th. Three analysts have rated the stock with a sell rating, nine have given a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, Aflac presently has a consensus rating of "Hold" and a consensus target price of $106.93.

Aflac Price Performance

AFL traded up $0.39 during trading on Tuesday, hitting $103.27. The company's stock had a trading volume of 361,913 shares, compared to its average volume of 2,108,961. The company has a current ratio of 0.09, a quick ratio of 0.09 and a debt-to-equity ratio of 0.29. Aflac has a twelve month low of $88.00 and a twelve month high of $115.50. The business's fifty day simple moving average is $104.14 and its 200 day simple moving average is $105.29. The firm has a market capitalization of $55.83 billion, a price-to-earnings ratio of 16.14, a P/E/G ratio of 3.24 and a beta of 0.81.

Aflac (NYSE:AFL - Get Free Report) last issued its quarterly earnings data on Wednesday, April 30th. The financial services provider reported $1.66 EPS for the quarter, missing the consensus estimate of $1.67 by ($0.01). Aflac had a net margin of 21.27% and a return on equity of 15.55%. The business had revenue of $3.40 billion during the quarter, compared to analyst estimates of $4.53 billion. During the same period in the previous year, the business posted $1.66 earnings per share. The firm's revenue for the quarter was down 37.5% on a year-over-year basis. On average, equities research analysts forecast that Aflac will post 6.88 EPS for the current fiscal year.

Insider Activity

In other news, Director Masatoshi Koide sold 37,000 shares of Aflac stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $105.59, for a total value of $3,906,830.00. Following the completion of the sale, the director directly owned 70,992 shares of the company's stock, valued at approximately $7,496,045.28. The trade was a 34.26% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Arthur Reginald Collins sold 2,750 shares of Aflac stock in a transaction on Thursday, May 15th. The shares were sold at an average price of $105.70, for a total value of $290,675.00. Following the completion of the transaction, the director owned 6,728 shares of the company's stock, valued at approximately $711,149.60. This trade represents a 29.01% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 40,750 shares of company stock valued at $4,304,295. 0.80% of the stock is currently owned by corporate insiders.

Institutional Trading of Aflac

A number of institutional investors have recently bought and sold shares of the business. AlphaCore Capital LLC purchased a new stake in shares of Aflac in the 1st quarter valued at about $28,000. Golden State Wealth Management LLC lifted its holdings in shares of Aflac by 121.9% in the 1st quarter. Golden State Wealth Management LLC now owns 304 shares of the financial services provider's stock valued at $34,000 after purchasing an additional 167 shares during the last quarter. Groupe la Francaise purchased a new stake in shares of Aflac in the 1st quarter valued at about $34,000. Garde Capital Inc. purchased a new stake in shares of Aflac in the 1st quarter valued at about $36,000. Finally, Meeder Asset Management Inc. lifted its holdings in shares of Aflac by 90.8% in the 1st quarter. Meeder Asset Management Inc. now owns 330 shares of the financial services provider's stock valued at $37,000 after purchasing an additional 157 shares during the last quarter. 67.44% of the stock is owned by hedge funds and other institutional investors.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.